Vol 79, No 7-8 (2021)
Editorial
Published online: 2021-06-01

open access

Page views 818
Article views/downloads 890
Get Citation

Connect on Social Media

Connect on Social Media

The intriguing association between patent foramen ovale and atrial fibrillation

J David Spence123, Luciano A Sposato234567
Pubmed: 34060639
Kardiol Pol 2021;79(7-8):725-727.

Abstract

Not available

References

  1. Kiełbasa G, Bednarek A, Bednarski A, et al. Patent foramen ovale and left atrial appendage flow velocity predict atrial fibrillation recurrence post cryoballoon ablation. Kardiol Pol. 2021; 79(7-8): 756–764.
  2. Jin X, Pan J, Wu H, et al. Are left ventricular ejection fraction and left atrial diameter related to atrial fibrillation recurrence after catheter ablation? A meta-analysis. Medicine (Baltimore). 2018; 97(20): e10822.
  3. Ngai J, Leonard J, Echevarria G, et al. Left atrial appendage velocity as a predictor of atrial fibrillation after cardiac surgery. J Cardiothorac Vasc Anesth. 2016; 30(2): 413–417.
  4. Knecht S, Wright M, Lellouche N, et al. Impact of a patent foramen ovale on paroxysmal atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2008; 19(12): 1236–1241.
  5. Daher G, Hassanieh I, Malhotra N, et al. Patent foramen ovale prevalence in atrial fibrillation patients and its clinical significance; a single center experience. Int J Cardiol. 2020; 300: 165–167.
  6. Sposato LA, Spence JD. Patent foramen ovale in patients with atrial fibrillation. Int J Cardiol. 2020; 300: 168–169.
  7. Strambo D, Sirimarco G, Nannoni S, et al. Embolic stroke of undetermined source and patent foramen ovale: risk of paradoxical embolism score validation and atrial fibrillation prediction. Stroke. 2021; 52(5): 1643–1652.
  8. Spence JD. Anticoagulation in patients with embolic stroke of unknown source. Int J Stroke. 2019; 14(4): 334–336.
  9. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984; 59(1): 17–20.
  10. Tobe J, Bogiatzi C, Munoz C, et al. Transcranial doppler is complementary to echocardiography for detection and risk stratification of patent foramen ovale. Can J Cardiol. 2016; 32(8): 986.e9–986.e16.
  11. Berthet K, Lavergne T, Cohen A, et al. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke. 2000; 31(2): 398–403.
  12. Packer M. Characterization, pathogenesis, and clinical implications of inflammation-related atrial myopathy as an important cause of atrial fibrillation. J Am Heart Assoc. 2020; 9(7): e015343.
  13. Chen JZJ, Thijs VN. Atrial fibrillation following patent foramen ovale closure: systematic review and meta-analysis of observational studies and clinical trials. Stroke. 2021; 52(5): 1653–1661.
  14. Kheiri B, Abdalla A, Osman M, et al. Percutaneous closure of patent foramen ovale in migraine: a meta-analysis of randomized clinical trials. JACC Cardiovasc Interv. 2018; 11(8): 816–818.



Polish Heart Journal (Kardiologia Polska)